Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-445-0 | CAS number: 106-94-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation, other
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 13th October - 14th November 1994
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Study conducted in compliance with agreed protocols, with no or minor deviations from standard test guidelines and/or minor methodological deficiencies, which do not affect the quality of the relevant results.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 995
- Report date:
- 1995
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- Justification for not using non-LLNA method is lack of availability.
The Local Lymph Node Assay (LLNA) OECD testing guideline No. 429 was first adopted in 2002. The information on sensitization potential of the substance was generated in 1995 according the OECD guidelines No. 406, which were accepted in these years.
Test material
- Reference substance name:
- 1-bromopropane
- EC Number:
- 203-445-0
- EC Name:
- 1-bromopropane
- Cas Number:
- 106-94-5
- Molecular formula:
- CH3CH2CH2Br
- IUPAC Name:
- 1-bromopropane
- Details on test material:
- 99.3 % purity
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Centre d'Elevage Lebau, 78950 Gambais, France
- Age at study initiation: NDA
- Weight at study initiation: 343 ± 22 g
- Housing: Individually in polycarbonate cages (48 x 27 x 20 cm) fitted with a polypropylene bottle
- Diet (e.g. ad libitum): Animals had free access to 106 diet (U.A.R., 91360 Villemoisson-sur-Orge, France)
- Water (e.g. ad libitum): Animals had free access to drinking water, filtered by a F.G. Millipore membrane
- Acclimation period: At least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21 ± 2 ºC
- Humidity (%): 30 to 70 %
- Air changes (per hr): 12 cycles / hours of filtered, non-recycled air
- Photoperiod (hrs dark / hrs light): 12/2
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal and epicutaneous
- Vehicle:
- paraffin oil
- Concentration / amount:
- 1, 5 and 25 % for the prelimiary study.
100 % for the main study.
Challengeopen allclose all
- Route:
- epicutaneous, occlusive
- Vehicle:
- paraffin oil
- Concentration / amount:
- 1, 5 and 25 % for the prelimiary study.
100 % for the main study.
- No. of animals per dose:
- 5 control and 10 test animals.
- Details on study design:
- RANGE FINDING TESTS:
A preliminary test was performed to determine the concentration to be used in the main study.
By intradermal route:
Determination of the Minimum Irritant Concentration (M.I.C.):
- 24 hours before treatment, the dorsal region of the animals was clipped,
- the test substance was prepared in an appropriate vehicle,
- intradermal administration of the test substance (volume 0.1 ml) at increasing concentrations was performed in order to determine the minimum concentration which does causes an irritation,
- evaluation of the potential cutaneous reactions, 24 and 48 hours after injection,
By cutaneous route:
Determination of the Minimum Irritant Conrtration (M.I.C.) and Maximum Non-Irritant Concentration (M.N.I.C.):
- 24 hours before treatment, the dorsal region of the animals was clipped,
- 0.5 ml of the test substance undiluted was applied to a gauze patch of approximately 4 cm and then held in place by an occlusive dressing for 24 hours,
- potential cutaneous reactions were evaluated 24 and 48 hours after removal of the gauze pads.
MAIN STUDY
A. INDUCTION EXPOSURE
Intradermal route:
On day 1, six intradermal injections were made into a clipped area (4 cm x 2 cm) in the scapular region. Three injections of 0.1 ml were injected into each side of the animal, as follows:
Control group:
• Freund's complete adjuvant diluted to 50% (v/v) with a sterile isotonic saline solution (0.9% NaCI),
• Vehicle,
• A mixture of 50/50 (w/v) Freund's complete adjuvant diluted to 50% (v/v) with a sterile isotonic aqueous NaCl solution and the vehicle.
Treated group:
• Freund's complete adjuvant diluted to 50% (v/v) with a sterile isotonic saline solution (0.9% NaCl)
• Test substance at a concentration of 25% (w/w) in the vehicle,
• A mixture 50/50 (w/v) of Freund's complete adjuvant diluted to 50% (v/v) with a sterile isotonic saline solution (0.9% NaCI), and, the test substance at a concentration of 25 (w/w) in the vehicle.
Cutaneous route:
On day 7, the scapular area was clipped. As the test substance is shown to be non-irritant after occlusive cutaneous treatment during preliminary test, the animals were treated with 0.5 ml of sodium laurylsulphate (10%) in vaseline to provoke local irritation.
On day 8, a cutaneous application on the 6 injection areas (4 cm x 2 cm) of the scapular region was performed.
Control group:
• Application of 0.5 ml of the vehicle.
Treated group:
• Application of 0.5 ml of a non-irritant concentration of the test substance i.e. in its original form.
The test substance and the vehicle were prepared on a dry gauze pad, which was then applied to the scapular region and held in place for 48 hours by means of an adhesive hypoallergenic dressing and an adhesive anallergenic waterproof plaster. No residual test substance was observed at removal of the dressing.
One hour after removal of the occlusive dressing, cutaneous reactions were recorded.
B. CHALLENGE EXPOSURE
At the end of the rest period on day 22, the test substance was applied at the Maximum Non-Irritant Concentration (M.N.I.C.) i.e. in its original form.
On day 22, the animals from both groups received an application of 0.5 ml of the M.N.I.C. of the test substance on the posterior right flank, and 0.5 ml of the vehicle on the posterior left flank. This application was performed using a I ml plastic syringe. The test substance and vehicle were prepared on a dry gauze pad, then applied to a 4 cm^2 (2 cm x 2 cm) clipped area of he skin. The gauze pad was held in contact with the skin for 24 hours by means of an occlusive, hypoallergenic dressing and an adhesive anallergenic waterproof plaster.
No residual test substance was observed at removal of the dressing. - Positive control substance(s):
- no
Study design: in vivo (LLNA)
- Statistics:
- % of animals showing a reaction Allerginicity Level Classification
0 - 8 I Very weak
9 - 28 II Weak
29 - 64 III Moderate
65 - 80 IV Strong
81 - 100 V Very Strong
Results and discussion
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 0 % test substance
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 0 % test substance. No with. + reactions: 0.0. Total no. in groups: 5.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 0 % test substance
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 0 % test substance. No with. + reactions: 0.0. Total no. in groups: 5.0.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 100 %
- No. with + reactions:
- 4
- Total no. in group:
- 10
- Clinical observations:
- 3 animals with very slight and 1 with well defined erythema
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 100 %. No with. + reactions: 4.0. Total no. in groups: 10.0. Clinical observations: 3 animals with very slight and 1 with well defined erythema.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 100 %
- No. with + reactions:
- 3
- Total no. in group:
- 10
- Clinical observations:
- 2 animals with very slight and 1 with well defined erythema
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 100 %. No with. + reactions: 3.0. Total no. in groups: 10.0. Clinical observations: 2 animals with very slight and 1 with well defined erythema.
Any other information on results incl. tables
Very slight to well defined erythema was observed in 40% of the animals after 24 hours and 30 % after 48 hours of the removal of the dressing. Dryness of the skin was oberved in 3/10 animals at the 48 hour reading. No oedema was observed 24 and 48 hours after removal of the dressing of the challenge cutaneous application of the test substance.
Microscopic Examination
Skin of the treated right flank (100 % concentration test substance) was examined in 4/10 females showing cutaneous reactions.
Slight to moderate acanthosis, sometimes together with minimal hyperkeratosis was noted in all 4 females. This was associated with minimal mononuclear cell and minimal to slight granulocyte inflamation if the upper dermis in all 4 females; extravasation of red blood cells was noted in the upper dermis of 1/4 examined females.
No treated skin from the 4/10 examined females showed spongiosis and in the absence of the classical association of spongiosis, acanthosis and mononuclear cell infiltration of dermis, the above mentioned lesions reported in 4/10 examined females were equivocal.
Acanthosis can be seen in cases of irritative inflammatory reaction and the minimal microscopic changes noted in the 4/10 examined females might be related to application of the test substance at 100 % concentration and/or shaving.
Applicant's summary and conclusion
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information
- Conclusions:
- Under experimental conditions and according to the maximization method of Magnusson and Kligman, no cutaneous reactions possibly attributable to the sensitization potential of the test substance, n-propyl bromide, in its original form were observed in guinea-pigs
- Executive summary:
A skin sensitization study according to the maximisation method of Magnusson and Kligman was performed on female Dunkin-Hartley guinea-pigs weighing 343 ± 22 g. The study was performed using the test substance 1-bromopropane and in accordance with OECD 406 and to GLP standard.
No cutaneous reactions possibly attributable to the sensitization potential of the test substance were observed and the material is therefore not classed as a sensitizer.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
